These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 532624)

  • 1. Myopathy induced by clofibrate treatment in normolipaemic patients.
    Cario WR; Hoffmann J; Hübschmann K; Kunze D; Regling G
    Acta Paediatr Acad Sci Hung; 1979; 20(1):1-9. PubMed ID: 532624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clofibrate-induced myopathy in patients with diabetes insipidus.
    Matsukura S; Matsumoto J; Chihara K; Yoshimoto Y; Fujita T
    Endocrinol Jpn; 1980 Jun; 27(3):401-3. PubMed ID: 7439122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical importance of clofibrate induced increase of creatine kinase catalytic activity concentration in serum.
    Schneider J
    J Clin Chem Clin Biochem; 1981 Aug; 19(8):539-40. PubMed ID: 7276838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Atypical muscular syndrome with myolysis during long-term treatment with fibrates].
    Chauvin M; Zupan M; Brechenmacher C
    Arch Mal Coeur Vaiss; 1988 Jul; 81(7):921-3. PubMed ID: 3142389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Creatinekinase in hyperlipoproteinemic patients treated with clofibrate.
    Schneider J; Mühlfellner G; Kaffarnik H
    Artery; 1980; 8(2):164-70. PubMed ID: 7458683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clofibrate-induced muscular syndrome. Report of a case with clinical, electromyographic and pathologic observations.
    Abourizk N; Khalil BA; Bahuth N; Afifi AK
    J Neurol Sci; 1979 Jun; 42(1):1-9. PubMed ID: 448390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clofibrate-induced myopathy in a patient with primary hypothyroidism.
    Hattori N; Shimatsu A; Murabe H; Nishimura M; Nakamura H; Imura H
    Jpn J Med; 1990; 29(5):545-7. PubMed ID: 2089182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clofibrate-induced muscle damage with myoglobinuria and cardiomyopathy.
    Smals AG; Beex LV; Kloppenborg PW
    N Engl J Med; 1977 Apr; 296(16):942. PubMed ID: 846520
    [No Abstract]   [Full Text] [Related]  

  • 9. Clofibrate myopathy: a case report and a review of the literature.
    Rush P; Baron M; Kapusta M
    Semin Arthritis Rheum; 1986 Feb; 15(3):226-9. PubMed ID: 3515563
    [No Abstract]   [Full Text] [Related]  

  • 10. Statin-associated myopathy with normal creatine kinase levels. Case report from a Norwegian family.
    Trøseid M; Henriksen OA; Lindal S
    APMIS; 2005 Sep; 113(9):635-7. PubMed ID: 16218940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing statin myopathy.
    Venero CV; Thompson PD
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):121-36. PubMed ID: 19217515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacological antidiuresis in diabetes insipidus. 3. Clofibrate].
    Cabezas-Cerrato J; Jímenez de Diego L; Fernández-Cruz A
    Rev Clin Esp; 1973 Dec; 131(6):455-60. PubMed ID: 4779999
    [No Abstract]   [Full Text] [Related]  

  • 13. Mitochondrial myopathy--a result of clofibrate/etofibrate treatment? Case report.
    Bardosi A; Scheidt P; Goebel HH
    Acta Neuropathol; 1985; 68(2):164-8. PubMed ID: 4072624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gemfibrozil-induced myopathy.
    Magarian GJ; Lucas LM; Colley C
    Arch Intern Med; 1991 Sep; 151(9):1873-4. PubMed ID: 1888257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combined clofibrate-chlorpropamide therapy in diabetes insipidus complicated with diabetes mellitus].
    Czakó L; László FA; Kahán-László I
    Endokrinologie; 1975 Aug; 65(3):364-74. PubMed ID: 1236680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clofibrate-induced muscular syndrome. Case report with ultrastructural findings and review of the literature.
    Rimon D; Ludatscher R; Cohen L
    Isr J Med Sci; 1984 Nov; 20(11):1082-6. PubMed ID: 6511338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diabetic nephropathy, hypothyroidism and colfibrate-induced myopathy (author's transl)].
    Rumpf KW; Quellhrost E; Scheler F
    Med Klin; 1976 Nov; 71(46):2023-7. PubMed ID: 995042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of diabetes insipidus in children and adolescents with clofibrate].
    Bittel-Dobrzyńska N
    Pediatr Pol; 1978 Jan; 53(1):61-70. PubMed ID: 643403
    [No Abstract]   [Full Text] [Related]  

  • 19. [Plasma renin activity in vasopressin-sensitive diabetes insipidus and changes in the same produced by clofibrate, carbamazepine and exogenous ADH].
    Holgado Silva C; Inoriza Rueda B; Vega Vázquez JM; Páez Antúnes C; Aznar Martín A; Carranza Conde M; Sánchez Burgos R; Aznar Reig A
    Rev Clin Esp; 1981 Jun 15-30; 161(5-6):311-3. PubMed ID: 7027368
    [No Abstract]   [Full Text] [Related]  

  • 20. Enzyme elevation in patients with juvenile dermatomyositis and steroid myopathy.
    Naim MY; Reed AM
    J Rheumatol; 2006 Jul; 33(7):1392-4. PubMed ID: 16821273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.